Zobrazeno 1 - 10
of 95
pro vyhledávání: '"Luke F Chen"'
Autor:
Deverick J Anderson, Leoncio Flavio Rojas, Shera Watson, Lauren P Knelson, Sohayla Pruitt, Sarah S Lewis, Rebekah W Moehring, Emily E Sickbert Bennett, David J Weber, Luke F Chen, Daniel J Sexton, CDC Prevention Epicenters Program
Publikováno v:
PLoS ONE, Vol 12, Iss 5, p e0176285 (2017)
The rate of community-acquired Clostridium difficile infection (CA-CDI) is increasing. While receipt of antibiotics remains an important risk factor for CDI, studies related to acquisition of C. difficile outside of hospitals are lacking. As a result
Externí odkaz:
https://doaj.org/article/20e25b3af56c40b7a80b9006c95080ae
Autor:
Rebekah W Moehring, Richard Sloane, Luke F Chen, Emily C Smathers, Kenneth E Schmader, Vance G Fowler, David J Weber, Daniel J Sexton, Deverick J Anderson
Publikováno v:
PLoS ONE, Vol 8, Iss 10, p e76225 (2013)
BACKGROUND:Gram-negative bacterial bloodstream infection (BSI) is a serious condition with estimated 30% mortality. Clinical outcomes for patients with severe infections improve when antibiotics are appropriately chosen and given early. The objective
Externí odkaz:
https://doaj.org/article/6a53f10ece4a4968b408c6b59c314d54
Autor:
Deverick J Anderson, Keith S Kaye, Luke F Chen, Kenneth E Schmader, Yong Choi, Richard Sloane, Daniel J Sexton
Publikováno v:
PLoS ONE, Vol 4, Iss 12, p e8305 (2009)
The clinical and financial outcomes of SSIs directly attributable to MRSA and methicillin-resistance are largely uncharacterized. Previously published data have provided conflicting conclusions.We conducted a multi-center matched outcomes study of 65
Externí odkaz:
https://doaj.org/article/5199e0a1fc0e4f1cbff2703bf0ed9972
Autor:
Ignacio Martin-Loeches, Andrew F Shorr, Marin H Kollef, Jiejun Du, Maria C Losada, Amanda Paschke, C Andrew DeRyke, Michael Wong, Erin H Jensen, Luke F Chen
Publikováno v:
Open Forum Infectious Diseases.
Background In the RESTORE-IMI 2 trial, imipenem/cilastatin/relebactam (IMI/REL) was noninferior to piperacillin/tazobactam in treating hospital-acquired bacterial pneumonia/ventilator-associated bacterial pneumonia. This post hoc analysis was conduct
Autor:
Jason A Roberts, David P Nicolau, Ignacio Martin-Loeches, C Andrew Deryke, Maria C Losada, Jiejun Du, Munjal Patel, Matthew L Rizk, Amanda Paschke, Luke F Chen
Publikováno v:
JAC-Antimicrobial Resistance. 5
ObjectivesTo assess the relationship between renal function and efficacy/safety of imipenem/cilastatin/relebactam for the treatment of hospital-acquired/ventilator-associated pneumonia (HABP/VABP) from RESTORE-IMI 2 and determine the PTA.MethodsAdult
Autor:
Nicholas A. Kartsonis, Antoine Roquilly, Robert W. Tipping, Luke F Chen, Aileen David-Wang, Richard G. Wunderink, Joan R. Butterton, Daniel Gonzalez, Jiejun Du, Munjal Patel, Keith S Kaye, Katherine Young, Ivan Titov, Michelle L Brown, Maria C Losada, Amanda Paschke, Helen W. Boucher, Matthew L. Rizk
Publikováno v:
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Background Imipenem combined with the β-lactamase inhibitor relebactam has broad antibacterial activity, including against carbapenem-resistant gram-negative pathogens. We evaluated efficacy and safety of imipenem/cilastatin/relebactam in treating h
Autor:
Deverick J. Anderson, Christopher W. Woods, Maria F. Gergen, Olga Better, Luke F. Chen, David J. Weber, Lauren P. Knelson, Daniel J. Sexton, William A. Rutala, Cdc Prevention Epicenters Program, Bradly P. Nicholson
Publikováno v:
Infection Control & Hospital Epidemiology. 40:47-52
ObjectiveHospital environmental surfaces are frequently contaminated by microorganisms. However, the causal mechanism of bacterial contamination of the environment as a source of transmission is still debated. This prospective study was performed to
Autor:
Sarah S. Lewis, Lauren P. Knelson, Luke F. Chen, Daniel J. Sexton, Paul Becherer, David J. Weber, William A. Rutala, Deverick J. Anderson, J. Conrad Schwab, Patricia F Triplett, Yuliya Lokhnygina, Rebekah W. Moehring, Michael Blocker
Publikováno v:
The Lancet Infectious Diseases. 18:845-853
Summary Background The hospital environment is a source of pathogen transmission. The effect of enhanced disinfection strategies on the hospital-wide incidence of infection has not been investigated in a multicentre, randomised controlled trial. We a
Autor:
Emily E. Sickbert-Bennett, Hajime Kanamori, William A. Rutala, Deverick J. Anderson, Daniel J. Sexton, Lauren P. Knelson, David J. Weber, Luke F. Chen, Maria F. Gergen
Publikováno v:
Infection Control & Hospital Epidemiology. 39:1118-1121
In this prospective study, we monitored 4 epidemiologically important pathogens (EIPs): methicillin-resistane Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE), Clostridium difficile, and multidrug-resistant (MDR) Acinetobacter to
Autor:
Lauren P. Knelson, Sarah S. Lewis, David J. Weber, R. Marty Cooney, Daniel J. Sexton, J. Conrad Schwab, William A. Rutala, Patricia F Triplett, Rebekah W. Moehring, Yuliya Lokhnygina, Luke F. Chen, Deverick J. Anderson, Michael Blocker
Publikováno v:
Infection Control & Hospital Epidemiology. 39:157-163
OBJECTIVETo summarize and discuss logistic and administrative challenges we encountered during the Benefits of Enhanced Terminal Room (BETR) Disinfection Study and lessons learned that are pertinent to future utilization of ultraviolet (UV) disinfect